Silo Pharma files patent for ibogaine treatment targeting brain injury
Go back to Silo Pharma files patent for ibogaine treatment targeting brain injury| (NASDAQ: SILO) | Delayed: 6.04 -0.08 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.12 | 52 Week High | $ | |||
| Open | $6.12 | 52 Week Low | $ | |||
| Day High | $6.37 | P/E | N/A | |||
| Day Low | $5.93 | EPS | $ | |||
| Volume | 18,339 | |||||

